Zynerba Pharma CS (ZYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZYNE | SLGL | MGX | ||
| Company | Zynerba Pharma CS | Sol-Gel Technologies Ltd | Metagenomi Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.2600 | 79.45 | 1.2100 | ||
| High | 1.3400 | 83.21 | 1.2500 | ||
| Low | 1.2600 | 78.59 | 1.2100 | ||
| Last | 1.3000 | 78.59 | 1.2400 | ||
| Change | +0.0300 | -0.74 | +0.0300 | ||
| Percent Change | +2.36% | -0.93% | +2.48% | ||
| Volume | 862,700 | 33,300 | 248,100 | ||
| 20-Day Average Volume | 1,093,995 | 58,740 | 118,645 | ||
| Previous | 1.2700 | 79.33 | 1.2100 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.3012 | 82.43 | 1.2180 | ||
| 20-Day Raw Stochastic | 53.49% | 38.94% | 85.71% | ||
| 20-Day Relative Strength | 62.80 | 48.75 | 50.37 | ||
| Weighted Alpha | -35.90 | +137.25 | -35.35 | ||
| Today's Opinion | 80% Buy | 72% Buy | 56% Sell | ||
| Yesterday's Opinion | 80% Buy | 72% Buy | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 72% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.17% since 10/03/23 | +9.92% since 08/12/26 | +1.64% since 08/12/26 | ||
| Low | 1.1850 on 10/04/23 | 71.80 on 08/13/26 | 1.2000 on 08/14/26 | ||
| High | 1.3400 on 10/10/23 | 90.79 on 08/14/26 | 1.2500 on 08/19/26 | ||
| 1-Month | |||||
| %Chg | -1.52% since 09/08/23 | -5.54% since 07/17/26 | unch since 07/17/26 | ||
| Low | 1.1850 on 10/04/23 | 70.81 on 08/12/26 | 1.1800 on 08/11/26 | ||
| High | 1.4000 on 09/15/23 | 93.74 on 07/22/26 | 1.3000 on 07/22/26 | ||
| 3-Month | |||||
| %Chg | +293.70% since 07/10/23 | +24.14% since 05/19/26 | -0.80% since 05/19/26 | ||
| Low | 0.2500 on 07/11/23 | 63.18 on 05/20/26 | 1.1300 on 06/17/26 | ||
| High | 1.4000 on 09/15/23 | 93.74 on 07/22/26 | 1.4200 on 05/27/26 | ||
| 6-Month | |||||
| %Chg | +225.00% since 04/10/23 | -2.80% since 02/19/26 | -18.42% since 02/19/26 | ||
| Low | 0.2500 on 07/11/23 | 61.92 on 03/23/26 | 1.1300 on 06/17/26 | ||
| High | 1.4000 on 09/15/23 | 97.97 on 03/03/26 | 1.8250 on 03/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 70,121 | 220,830 | 46,843 | ||
| Shares Outstanding, K | 53,939 | 2,810 | 37,777 | ||
| Annual Sales, $M | 0 | 19,390,000 | 25,210,000 | ||
| Annual Net Income, $M | -35,040,000 | -6,130,000 | -87,870,000 | ||
| Last Qtr Sales, $M | 0 | 110,000 | 1,250,000 | ||
| Last Qtr Income, $M | -10,780,000 | -3,730,000 | -23,060,000 | ||
| 60-Month Beta | 1.32 | 1.12 | 0.66 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 08/14/23 | -1.31 on 05/28/26 | -0.73 on 08/10/26 | ||
| Latest Earnings Date | 11/13/23 | 08/21/26 | 11/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||